BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26861456)

  • 1. Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group.
    Vo KT; Edwards JV; Epling CL; Sinclair E; Hawkins DS; Grier HE; Janeway KA; Barnette P; McIlvaine E; Krailo MD; Barkauskas DA; Matthay KK; Womer RB; Gorlick RG; Lessnick SL; Mackall CL; DuBois SG
    Clin Cancer Res; 2016 Jul; 22(14):3643-50. PubMed ID: 26861456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow.
    Dubois SG; Epling CL; Teague J; Matthay KK; Sinclair E
    Pediatr Blood Cancer; 2010 Jan; 54(1):13-8. PubMed ID: 19711435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of detection of CD99
    Zakzok O; Elshanshory M; Zekri W; Elsharkawy N; Zaky I; Salama A; Kamel A; Elantably I; Said S
    Pediatr Blood Cancer; 2022 Jan; 69(1):e29298. PubMed ID: 34403190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling.
    Manara MC; Terracciano M; Mancarella C; Sciandra M; Guerzoni C; Pasello M; Grilli A; Zini N; Picci P; Colombo MP; Morrione A; Scotlandi K
    Oncotarget; 2016 Nov; 7(48):79925-79942. PubMed ID: 27835596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ewing sarcoma of the small bowel: a study of seven cases, including one with the uncommonly reported EWSR1-FEV translocation.
    Milione M; Gasparini P; Sozzi G; Mazzaferro V; Ferrari A; Casali PG; Perrone F; Tamborini E; Pellegrinelli A; Gherardi G; Arrigoni G; Collini P; Testi A; De Paoli E; Aiello A; Pilotti S; Pelosi G
    Histopathology; 2014 Jun; 64(7):1014-26. PubMed ID: 24898918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.
    Thiel U; Wawer A; von Luettichau I; Bender HU; Blaeschke F; Grunewald TG; Steinborn M; Röper B; Bonig H; Klingebiel T; Bader P; Koscielniak E; Paulussen M; Dirksen U; Juergens H; Kolb HJ; Burdach SE
    Oncotarget; 2016 Oct; 7(43):70959-70968. PubMed ID: 27486822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized ewing tumor.
    Schleiermacher G; Peter M; Oberlin O; Philip T; Rubie H; Mechinaud F; Sommelet-Olive D; Landman-Parker J; Bours D; Michon J; Delattre O;
    J Clin Oncol; 2003 Jan; 21(1):85-91. PubMed ID: 12506175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted imaging of Ewing sarcoma in preclinical models using a 64Cu-labeled anti-CD99 antibody.
    O'Neill AF; Dearling JL; Wang Y; Tupper T; Sun Y; Aster JC; Calicchio ML; Perez-Atayde AR; Packard AB; Kung AL
    Clin Cancer Res; 2014 Feb; 20(3):678-87. PubMed ID: 24218512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated multimodal genetic testing of Ewing sarcoma--a single-institution experience.
    Warren M; Weindel M; Ringrose J; Venable C; Reyes A; Terashima K; Rao P; Chintagumpala M; Hicks MJ; Lopez-Terrada D; Lu XY
    Hum Pathol; 2013 Oct; 44(10):2010-9. PubMed ID: 23706910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumors, and desmoplastic small round cell tumor.
    Athale UH; Shurtleff SA; Jenkins JJ; Poquette CA; Tan M; Downing JR; Pappo AS
    J Pediatr Hematol Oncol; 2001 Feb; 23(2):99-104. PubMed ID: 11216714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular confirmation of Ewing sarcoma.
    Dagher R; Pham TA; Sorbara L; Kumar S; Long L; Bernstein D; Mackall C; Raffeld M; Tsokos M; Helman L
    J Pediatr Hematol Oncol; 2001 May; 23(4):221-4. PubMed ID: 11846300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ewing sarcoma with myxoid stroma: Case report of an unusual histological variant.
    Alexiev BA; Obeidin F; Jennings LJ
    Pathol Res Pract; 2019 Dec; 215(12):152665. PubMed ID: 31585812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic, immunohistochemical, molecular cytogenetic profile with treatment and outcomes of 34 cases of Ewing sarcoma with epithelial differentiation, including 6 cases with "Adamantinoma-like" features, diagnosed at a single institution, India.
    Rekhi B; Shetty O; Vora T; Gulia A; Bajpai J; Laskar S
    Ann Diagn Pathol; 2020 Dec; 49():151625. PubMed ID: 32932018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRM1 Inhibition Promotes Cytotoxicity in Ewing Sarcoma Cells by Repressing EWS-FLI1-Dependent IGF-1 Signaling.
    Sun H; Lin DC; Cao Q; Guo X; Marijon H; Zhao Z; Gery S; Xu L; Yang H; Pang B; Lee VK; Lim HJ; Doan N; Said JW; Chu P; Mayakonda A; Thomas T; Forscher C; Baloglu E; Shacham S; Rajalingam R; Koeffler HP
    Cancer Res; 2016 May; 76(9):2687-97. PubMed ID: 26956669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway.
    van Maldegem AM; Bovée JV; Peterse EF; Hogendoorn PC; Gelderblom H
    Eur J Cancer; 2016 Jan; 53():171-80. PubMed ID: 26765686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas.
    Asmane I; Watkin E; Alberti L; Duc A; Marec-Berard P; Ray-Coquard I; Cassier P; Decouvelaere AV; Ranchère D; Kurtz JE; Bergerat JP; Blay JY
    Eur J Cancer; 2012 Nov; 48(16):3027-35. PubMed ID: 22682017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Marrow Involvement in Metastatic Pediatric Ewing Sarcoma.
    Khan SJ; Ishaq I; Saeed H; Fayyaz MB; Baqari SAS; Wali RM
    J Coll Physicians Surg Pak; 2017 Aug; 27(8):502-504. PubMed ID: 28903844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-1R/MDM2 relationship confers enhanced sensitivity to RITA in Ewing sarcoma cells.
    Di Conza G; Buttarelli M; Monti O; Pellegrino M; Mancini F; Pontecorvi A; Scotlandi K; Moretti F
    Mol Cancer Ther; 2012 Jun; 11(6):1247-56. PubMed ID: 22461661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma?
    Kasalak Ö; Glaudemans AWJM; Overbosch J; Jutte PC; Kwee TC
    Skeletal Radiol; 2018 Mar; 47(3):363-367. PubMed ID: 29124298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FLI1 and MIC2 expression in precursor B-lymphoblastic leukemia with Burkitt-like morphology and extensive extramedullary involvement: A diagnostic challenge in pediatric small round cell tumor.
    Das N; Thakral D; Singh G; Malhotra A; Phulware RH; Gogia A; Gupta R
    Indian J Pathol Microbiol; 2019; 62(4):614-617. PubMed ID: 31611454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.